- Home
- OPOF vs HLVX Comparison
OPOF vs HLVX Comparison
Compare OPOF & HLVX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OPOF
- HLVX
- Stock Information
- Founded
- OPOF 1922
- HLVX 2020
- Country
- OPOF United States
- HLVX United States
- Employees
- OPOF N/A
- HLVX N/A
- Industry
- OPOF Major Banks
- HLVX Biotechnology: Pharmaceutical Preparations
- Sector
- OPOF Finance
- HLVX Health Care
- Exchange
- OPOF Nasdaq
- HLVX Nasdaq
- Market Cap
- OPOF 103.7M
- HLVX 87.6M
- IPO Year
- OPOF N/A
- HLVX 2022
- Fundamental
- Price
- OPOF $21.32
- HLVX $1.86
- Analyst Decision
- OPOF
- HLVX Hold
- Analyst Count
- OPOF 0
- HLVX 5
- Target Price
- OPOF N/A
- HLVX $2.33
- AVG Volume (30 Days)
- OPOF 20.3K
- HLVX 133.4K
- Earning Date
- OPOF 10-24-2024
- HLVX 11-07-2024
- Dividend Yield
- OPOF 2.59%
- HLVX N/A
- EPS Growth
- OPOF N/A
- HLVX N/A
- EPS
- OPOF 1.60
- HLVX N/A
- Revenue
- OPOF $59,503,000.00
- HLVX N/A
- Revenue This Year
- OPOF N/A
- HLVX N/A
- Revenue Next Year
- OPOF N/A
- HLVX N/A
- P/E Ratio
- OPOF $12.95
- HLVX N/A
- Revenue Growth
- OPOF N/A
- HLVX N/A
- 52 Week Low
- OPOF $13.49
- HLVX $1.55
- 52 Week High
- OPOF $21.89
- HLVX $20.22
- Technical
- Relative Strength Index (RSI)
- OPOF 63.59
- HLVX 49.50
- Support Level
- OPOF $20.30
- HLVX $1.78
- Resistance Level
- OPOF $21.89
- HLVX $2.02
- Average True Range (ATR)
- OPOF 0.66
- HLVX 0.07
- MACD
- OPOF -0.03
- HLVX -0.01
- Stochastic Oscillator
- OPOF 51.10
- HLVX 34.04
About OPOF Old Point Financial Corporation
Old Point Financial Corp functions in the financial services domain in the United States. As the holding company of The Bank and Trust, it is a nationally chartered trust and wealth management service, provider. Its suite of services includes commercial banking solutions such as loan, deposit and cash management, which are rendered through a chain of branches throughout the country. It operates through segments such as Bank, Wealth and Company.
About HLVX HilleVax Inc.
HilleVax Inc is a clinical-stage biopharmaceutical company. The company is focused on developing and commercializing novel vaccines. The firm's initial program, HIL-214, is a virus-like particle (VLP) based vaccine candidate for the prevention of moderate-to-severe acute gastroenteritis (AGE) caused by norovirus infection.